About
Auxilius Pharma is developing AUX-001, a pharmaceutical treatment based on nicorandil for chronic stable angina that targets both macrovascular and microvascular symptoms and reduces hospitalizations.
Explore Auxilius Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.